Search Results - "Dalvi, T.B."

Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN by Paz-Ares, L., Chen, Y., Reinmuth, N., Hotta, K., Trukhin, D., Statsenko, G., Hochmair, M.J., Özgüroğlu, M., Ji, J.H., Garassino, M.C., Voitko, O., Poltoratskiy, A., Musso, E., Havel, L., Bondarenko, I., Losonczy, G., Conev, N., Mann, H., Dalvi, T.B., Jiang, H., Goldman, J.W.

“…In the phase III CASPIAN study, first-line durvalumab in combination with etoposide plus either cisplatin or carboplatin (EP) significantly improved overall…”
Get full text

1530P Durvalumab (D) + platinum-etoposide (EP) in first-line extensive-stage SCLC (ES SCLC): Effect of age and platinum agent on outcomes in CASPIAN by Reinmuth, N., Goldman, J.W., Chen, Y., Hotta, K., Statsenko, G., Hochmair, M.J., Özgüroğlu, M., Ji, J.H., Garassino, M.C., Poltoratskiy, A., Verderame, F., Havel, L., Bondarenko, I., Losonczy, G., Conev, N.V., Mann, H., Chugh, P., Dalvi, T.B., Paz-Ares, L.

Get full text

Dietary Patterns and Risk of Ovarian Cancer in the California Teachers Study Cohort by Chang, E.T, Lee, V.S, Canchola, A.J, Dalvi, T.B, Clarke, C.A, Reynolds, P, Purdie, D.M, Stram, D.O, West, D.W, Ziogas, A

“…Previous studies have examined the association between individual foods or nutrients, but not overall diet, and ovarian cancer risk. To account for the…”
Get full text